My bookmarksSign up free

Regulation (EU) No 536/2014 Article 45

Regulation (EU) No 536/2014 Article 45

Technical aspects

Article 45

Technical aspects for safety reporting in accordance with Articles 41 to 44 are contained in Annex III. Where necessary in order to improve the level of protection of subjects, the Commission shall be empowered to adopt delegated acts in accordance with Article 89 in order to amend Annex III for any of the following purposes: (a) improving the information on the safety of medicinal products; (b) adapting technical requirements to technical progress; (c) taking account of international regulatory developments in the field of safety requirements in clinical trials, endorsed by bodies in which the Union or the Member States participate.

Read the full instrument → · Read this in context: CHAPTER VII — SAFETY REPORTING IN THE CONTEXT OF A CLINICAL TRIAL →

Other provisions in CHAPTER VII — SAFETY REPORTING IN THE CONTEXT OF A CLINICAL TRIAL

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationArticle 45 of Regulation (EU) No 536/2014 (LawPlayer, data as of 2026-07-04)

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

What to look at next